SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-055156
Filing Date
2023-03-01
Accepted
2023-03-01 07:30:58
Documents
12
Period of Report
2023-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d446194d8k.htm   iXBRL 8-K 31612
  Complete submission text file 0001193125-23-055156.txt   155925

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tyra-20230227.xsd EX-101.SCH 2829
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20230227_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20230227_pre.xml EX-101.PRE 11244
6 EXTRACTED XBRL INSTANCE DOCUMENT d446194d8k_htm.xml XML 3343
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 23689794
SIC: 2834 Pharmaceutical Preparations